Showing results (1-10 of 266) with videos related to
Sort By:
Pageof 27
Current Opinion in Rheumatology|August 18, 2016
Animal models of scleroderma: recent progressRoberta G Marangoni, John Varga, Warren G TourtellotteOncotarget|March 15, 2018
The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic targetJun Wei, Roberta G Marangoni, Feng Fang, et al.JCI Insight|September 6, 2022
Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in sclerodermaRoberta G Marangoni, Poulami Datta, Ananta Paine, et al.Current Opinion in Rheumatology|August 12, 2017
The roles of dermal white adipose tissue loss in scleroderma skin fibrosisRoberta G Marangoni, Theresa T LuArthritis Research & Therapy|October 25, 2012
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapyFeng Fang, Lei Liu, Yang Yang, et al.Spine|March 16, 2010
Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapyRoberta G Marangoni, Ari S R HalpernTranslational Research : the Journal of Laboratory and Clinical Medicine|December 29, 2016
Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivativeJun Wei, Hongyan Zhu, Gabriel Lord, et al.Bulletin of the NYU Hospital for Joint Diseases|October 22, 2008
Systemic sclerosis: an updateJohn VargaCurrent Rheumatology Reports|March 16, 2004
Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts?John VargaRevista Do Instituto De Medicina Tropical De Sao Paulo|May 29, 2012
Amplification of the flgE gene provides evidence for the existence of a Brazilian borreliosisElenice Mantovani, Roberta G Marangoni, Giancarla Gauditano, et al.Pageof 27